OpZira, Inc. is a forward-thinking ophthalmic medical device company founded on a legacy of research excellence. We deliver innovative technologies designed to enhance the detection and monitoring of ocular disease.  

AdaptDx Pro® is a wearable dark adaptometer leveraging AI to ensure a consistent patient experience. Impaired dark adaptation speed – a key early indicator of rod-mediated dysfunction – is often one of the first functional signs of retinal disease. AdaptDx Pro is available in the U.S.

EVERGE™ Vision Testing System is a robust electrophysiology platform that provides objective assessments of the entire visual and neuro-visual pathway. VEP is available in the U.S. and select international markets. ERG is only available outside of the U.S.

For more information, visit OpZira.com.

OpZira, Inc.

Org chart

Teams

Offices